METHOD FOR THROMBIN AND FIBRINOGEN ACTIVITY AND FUNCTIONALITY TEST Russian patent published in 2012 - IPC G01N33/86 C12Q1/56 

Abstract RU 2462721 C2

FIELD: medicine.

SUBSTANCE: method for thrombin activity test in an initially non-reacted mixture of thrombin and fibrinogen (versions) involving the stages: (a) reversible thrombin inhibition by adding an inhibitory solution having pH varying within the range of 8.5 to 11.5; (b) addition of the known amount of fibrinogen to the mixture (or the known amount of a chromogenic or fluorogenic thrombin substrate), (c) reversible thrombin activation by pH reduction to approximately 6.0 to less than 8.5, (d) enabling thrombin reacting with fibrinogen, (e) thrombin activity test initially found in the dry mixture. The method for fibrinogen functionality test in an initially non-reacted mixture of thrombin and fibrinogen (versions) involving the stages: (a) reversible thrombin inhibition by adding an inhibitory solution having pH varying within the range of 8.5 to 11.5; (b) addition of the known amount of thrombin to the mixture (or a thrombin-like enzyme), (c) reversible thrombin activation by pH reduction to approximately 6.0 to less than 8.5, (d) enabling thrombin reacting with fibrinogen, (e) fibrinogen functionality test initially found in the dry mixture.

EFFECT: group of inventions enables higher accuracy of thrombin and fibrinogen activity test.

32 cl, 1 dwg

Similar patents RU2462721C2

Title Year Author Number
METHOD OF FIBRIN CLOT ADMINISTRATION (ITS VARIANTS) AND AGENT KIT FOR ITS ADMINISTRATION (VARIANTS) 1991
  • Brenda Mors Smit[Us]
  • A.Deniz Terner[Us]
  • Robert T.Maknehlli[Us]
RU2104701C1
FIBRINOGEN CONTENT ANALYSIS 2012
  • Dinglis Eshli
  • Burkoglu Elif
RU2619256C2
METHOD FOR PRODUCING HIGHLY VIRUS-SAFETY COMPONENTS FOR PREPARING FIBRIN GLUE FROM HUMAN PLASMA BLOOD POOL 1998
  • Bui-Khak Trung
RU2236237C2
METHOD OF PREPARING FERMENTATIVE PREPARATION POSSESSING HEMOSTATIC AND ANTICOAGULANT EFFECT 0
  • Edmund E.Pers
  • Kurt F.Shtokker
  • Birger Blombek
  • Margareta Blombek
  • Birgit Khessel
SU581872A3
ANTIFIBRIN ANTIBODY FOR USE AS ANTITHROMBOTIC AGENT 1995
  • Gargan Pol I.
RU2152801C2
METHOD FOR CLEANING FIBRINOGEN, FIBRINOGEN PRODUCT AND MEANS FOR CLEANING OR PRODUCING FIBRINOGEN PRODUCT 2013
  • Shults Petra
  • Geringer Verner
  • Pape Rajner
  • Remish Yurgen
  • Lyajtinger Karoline
  • Shen Fridrikh
RU2663792C2
METHOD OF QUANTITATIVE DETERMINATION OF FIBRINOGENS IN BLOOD PLASMA 0
  • Barkagan Zinovij Solomonovich
  • Tsyvkina Lyudmila Petrovna
SU1146002A1
FIBRIN/FIBRINOGEN-BINDING CONJUGATE 2001
  • Redl' Khajnts
  • Furst Val'Ter
  • Knajdinger Rudol'F
  • Khelgerson Sehm L.
  • Luker Duglas L.
  • Inman Ehlizabet M.
  • Richards Dzhejn P.
  • Vong Katalina
RU2279890C2
METHOD FOR OBTAINING PLATELET RELEASATE CONTAINING GROWTH FACTORS 2017
  • Guris, Teo
  • Fakhmi, Khossam Mustafa
RU2795884C2
METHOD OF PURIFYING THERAPEUTIC PROTEINS 2013
  • Pkham Khung
  • Khej Dzheffri Majkl
  • Ngui Darren
RU2685956C2

RU 2 462 721 C2

Authors

De Ehnglis Ehshli

Mejdler Roberto

Gorman Ehnn

Bar Liliana

Nur Izrael

Dates

2012-09-27Published

2008-05-22Filed